Altimmune, Inc. (ALT) stock
ALTNasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.53−0.03 (-1.92%)
Close on Nov 17, 2026Market cap $297.61MP/E –Yield –
Altimmune pe ratio
The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.
Altimmune's pe ratio was 0.2× on Jan 31, 2018.
PE Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2018 | Jan 31, 2018 | 0.2× | −0.0 |
| 2017 | Dec 29, 2017 | 0.3× | – |
See a number that looks wrong?